Company Filing History:
Years Active: 2015-2021
Title: Laurent Mascarell: Innovator in Immunotherapy
Introduction
Laurent Mascarell is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunotherapy, particularly in understanding allergic responses. With a total of 5 patents to his name, Mascarell's work has been influential in advancing medical research and treatment options.
Latest Patents
One of his latest patents is titled "IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy." This invention focuses on the use of IL-10 as a biological marker to predict how well a patient with house dust mite allergies will respond to immunotherapy. Another notable patent is "Markers of immune response," which outlines methods for determining the type of dendritic cells present in patients undergoing immunotherapy. This patent also includes techniques for assessing whether a patient is developing a regulatory T cell response or an effector type 2 cell response.
Career Highlights
Throughout his career, Laurent Mascarell has worked with notable companies such as Stallergenes and Stallergenes S.A. His expertise in immunology and allergy treatment has positioned him as a key figure in the development of innovative therapies.
Collaborations
Mascarell has collaborated with esteemed colleagues, including Philippe Moingeon and Emmanuel Nony. These partnerships have further enriched his research and contributed to the advancement of immunotherapy.
Conclusion
Laurent Mascarell's innovative work in immunotherapy and his contributions to understanding allergic responses have made a significant impact in the medical field. His patents and collaborations reflect his dedication to improving patient outcomes in allergy treatment.